FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia – U.S. News & World Report
U.S. News & World Report |
FDA OKs Pfizer Drug for Rare, Fast-Killing Type of Leukemia
U.S. News & World Report FDA approves new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. Aug. 17, 2017, at 5:35 p.m.. MORE. LinkedIn · StumbleUpon · Google +; Cancel. FDA OKs Pfizer Drug for Rare, Fast-Killing Type of … FDA approves Pfizer’s drug for rare blood cancer FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL New Treatment Approved for Deadly Blood Cancer |
View original article
Author:
Powered by WPeMatico